Latest news with #Stryker
Yahoo
2 days ago
- Business
- Yahoo
FDA grants 510(k) clearance to Stryker's total ankle system
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Stryker's Incompass Total Ankle System, designed for individuals whose ankle joints are damaged due to severe rheumatoid, degenerative, or post-traumatic arthritis. This implant integrates technologies of the company's Inbone and Infinity systems to offer a comprehensive, unified solution for total ankle replacement. The system features Adaptis Boney Ingrowth Technology and redesigned instrumentation for supporting long-term fixation and surgical flexibility. It is said to be tailored for addressing challenges such as intraoperative adaptability and procedural efficiency in ankle replacement surgeries. Incompass is the result of extensive research, including data from more than 85,000 computed tomography (CT) scans and 100,000 clinical cases. Developed using the Stryker Orthopaedic Modeling & Analytics (SOMA) platform, the combination of Incompass with arthritic ankle scans from the Prophecy surgical planning system offers implant and instrumentation options, catering to the varying needs of surgeons and the anatomy of patients. These enhancements include a redesigned alignment system, updated implant holders, and trial tools for better handling, as well as refinements to minimise surgical steps and set-up duration. Stryker Foot & Ankle business general manager and vice-president Adam Jacobs said: 'Incompass reflects our commitment to redefining what's possible in total ankle replacement. 'By building on decades of clinical experience and leveraging extensive data insights, we're setting a new standard—one that empowers surgeons to deliver more personalised care with greater efficiency and confidence.' Stryker provides products across various medical sectors, including MedSurg, neurotechnology, and orthopaedics. In February this year, the company acquired Inari Medical for a total equity value of nearly $4.9bn, marking a significant expansion into the venous thromboembolism (VTE) market. "FDA grants 510(k) clearance to Stryker's total ankle system" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Business
- Yahoo
Stryker receives FDA clearance for Incompass Total Ankle System
Streamlining total ankle replacement with data-driven implants and surgical flexibility PORTAGE, Mich., June 25, 2025--(BUSINESS WIRE)--Stryker (NYSE:SYK), a global leader in medical technologies, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Incompass® Total Ankle System, an implant intended for patients with ankle joints damaged by severe rheumatoid, post-traumatic, or degenerative arthritis. This new platform integrates the innovative technologies of Stryker's Inbone® and Infinity® systems into a single, comprehensive solution for total ankle replacement. "Incompass reflects our commitment to redefining what's possible in total ankle replacement," said Adam Jacobs, vice president and general manager of Stryker's Foot & Ankle business. "By building on decades of clinical experience and leveraging extensive data insights, we're setting a new standard—one that empowers surgeons to deliver more personalized care with greater efficiency and confidence." Incompass incorporates Adaptis® Boney Ingrowth Technology and redesigned instrumentation to support long-term fixation, surgical flexibility and streamlined workflow. Developed to address key challenges in total ankle replacement, including intraoperative adaptability and procedural efficiency, the system is informed by data from more than 85,000 CT scans¹ and 100,000 clinical cases.¹ It also offers a broad range of implant and instrumentation options to support patient-specific care. Built using the Stryker Orthopaedic Modeling & Analytics (SOMA) platform in combination with arthritic ankle scans from the company's Prophecy Surgical Planning System, Incompass provides a continuum of implant and instrument options designed to accommodate both surgeon preference and patient anatomy. System enhancements include a redesigned alignment system for greater control across multiple planes, updated implant holders and trial tools for improved handling, and instrumentation refinements designed to reduce surgical steps and set up time. About Stryker Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at Copyright © 2025 StrykerContent ID: FA-INCO-PRESS-2016296 References:1. Based on internal data as of 5/1/2025. View source version on Contacts Media contact Sampson Public Relations GroupAndrea SampsonPresident/CEO asampson@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
3 days ago
- Business
- Business Wire
Stryker receives FDA clearance for Incompass Total Ankle System
PORTAGE, Mich.--(BUSINESS WIRE)--Stryker (NYSE:SYK), a global leader in medical technologies, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Incompass® Total Ankle System, an implant intended for patients with ankle joints damaged by severe rheumatoid, post-traumatic, or degenerative arthritis. This new platform integrates the innovative technologies of Stryker's Inbone® and Infinity® systems into a single, comprehensive solution for total ankle replacement. 'Incompass reflects our commitment to redefining what's possible in total ankle replacement,' said Adam Jacobs, vice president and general manager of Stryker's Foot & Ankle business. 'By building on decades of clinical experience and leveraging extensive data insights, we're setting a new standard—one that empowers surgeons to deliver more personalized care with greater efficiency and confidence.' Incompass incorporates Adaptis® Boney Ingrowth Technology and redesigned instrumentation to support long-term fixation, surgical flexibility and streamlined workflow. Developed to address key challenges in total ankle replacement, including intraoperative adaptability and procedural efficiency, the system is informed by data from more than 85,000 CT scans¹ and 100,000 clinical cases.¹ It also offers a broad range of implant and instrumentation options to support patient-specific care. Built using the Stryker Orthopaedic Modeling & Analytics (SOMA) platform in combination with arthritic ankle scans from the company's Prophecy Surgical Planning System, Incompass provides a continuum of implant and instrument options designed to accommodate both surgeon preference and patient anatomy. System enhancements include a redesigned alignment system for greater control across multiple planes, updated implant holders and trial tools for improved handling, and instrumentation refinements designed to reduce surgical steps and set up time. About Stryker Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at Copyright © 2025 Stryker Content ID: FA-INCO-PRESS-2016296 References: 1. Based on internal data as of 5/1/2025.
Yahoo
5 days ago
- Business
- Yahoo
Medical Equipment And Supplies Market Outlook, Trends, Innovations and Growth
Luton, Bedfordshire, United Kingdom, June 23, 2025 (GLOBE NEWSWIRE) -- Medical Equipment & Supplies Market Report: 2024–2025 Overview The global medical equipment and supplies market is projected to reach a value of approximately $557 billion in 2024. This robust market is anticipated to experience significant growth, with a forecasted value of around $1 trillion by 2034, reflecting an impressive Compound Annual Growth Rate (CAGR) of about 6.7% during the 2025–2034 period. Download PDF Brochure: Foreword The medical equipment and supplies industry is a backbone of modern healthcare systems, driving innovations that support diagnostics, treatment, surgery, and patient care across clinical and home settings. As global healthcare systems undergo digital transformation, aging populations demand higher standards of care, and emerging markets expand access, the sector is poised for continued expansion. This report presents a comprehensive analysis of the medical equipment and supplies market, integrating financial outlooks, segment trends, key players, regulatory shifts, and technological developments that are shaping the landscape in 2024 and beyond. Market Size & Segmentation Global Valuation & Growth: USD 570.3 billion in 2024, projected to reach USD 840 billion by 2030, at a CAGR of 6.7%. Segmentation: By Product: Diagnostic imaging, surgical instruments, patient monitoring, disposable consumables, mobility aids, sterilization equipment. By End-User: Hospitals, ambulatory surgical centers, diagnostic labs, home care settings. By Application: Cardiovascular, orthopedics, respiratory, urology, neurology, ophthalmology. By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. Key Players Global Leaders: Medtronic, Johnson & Johnson, GE Healthcare, Siemens Healthineers, Stryker, Abbott, Philips Healthcare, Baxter, 3M Healthcare, Boston Scientific. Emerging & Mid-Tier Companies: B. Braun, Smith & Nephew, ConvaTec, ResMed, ICU Medical, Hill-Rom, Terumo, Nipro, Mindray, Masimo. Startups to Watch: Cala Health (neuromodulation), Kinsa (connected thermometers), SiBionics (wearable diagnostics), Exo (portable ultrasound). Key Market Events (2024–2025) Stryker launched the Mako Total Knee 2.0 robotics platform in March 2024, enhancing AI-assisted precision surgery. Medtronic received FDA approval for its Micra AV2 and VR2 leadless pacemakers. GE HealthCare completed acquisition of Caption Health, integrating AI ultrasound guidance. Philips launched the IntelliVue MX750 & MX850 patient monitors with advanced interoperability. Baxter divested its BioPharma Solutions business for $4.25B to refocus on core hospital equipment lines. Browse full Report - Recent Company Developments Boston Scientific: Introduced POLARx Cryoablation System in Europe for atrial fibrillation (2025). Johnson & Johnson MedTech: Debuted Ottava surgical robot prototype, targeting 2026 commercialization. Masimo: Expanded Rad-G Pulse Oximeter rollout across community clinics in Africa and Southeast Asia. ICU Medical: Advanced integration of Plum 360 infusion systems with hospital EHRs. ResMed: Launched AirCurve 11 series of bilevel devices with AI-enabled titration. Key Funding Deals (2024–2025) Exo: Raised $100M in Series C for AI-based handheld ultrasound devices. Huma Therapeutics: Secured $130M to expand remote patient monitoring platform. Noah Medical: Closed $150M Series B for advanced robotic bronchoscopy systems. Nanox: Raised $90M for commercializing digital X-ray technology. HeartFlow: Raised $215M to expand AI-based cardiovascular diagnostics. Government & Regulatory Developments FDA (U.S.): Updated Safer Technologies Program (STeP) guidance to accelerate approvals of low-risk innovations. European Union MDR: Full implementation enforced from January 2025, reshaping regulatory pathways. India: Expanded PLI scheme to medical device manufacturers with 5%–10% incentives. Japan: Streamlined reimbursement coding for remote diagnostics in national health insurance. Brazil: ANVISA fast-tracked essential surgical supply approvals amid demand surges. Most Sold Equipment & Supplies by Region USA: Top categories: Patient monitors, imaging systems (MRI/CT), surgical instruments, orthopedic implants. High volume devices: Infusion pumps (BD Alaris), ventilators (Philips Trilogy), ECGs (GE MAC series). Europe: Focus: High-end imaging, endoscopy, and robotic surgery (da Vinci, Mako). High sales: Diagnostic reagents, blood pressure monitors, portable ultrasounds. Asia-Pacific: Drivers: Rising demand in China, India, Southeast Asia; expansion in community and home-based devices. Popular items: Vital signs monitors, glucometers, oxygen concentrators. Latin America: High demand for: Sterile surgical kits, digital thermometers, portable ECGs. Main channels: Public health procurement, international aid, private clinics. Volume-Based Rankings & Sales Insights Global MRI scanner shipments: ~6,500 units in 2024; Siemens, GE, Philips dominate. Infusion pumps: Over 300,000 units sold globally in 2024. Surgical kits & disposables: Account for 45% of global volume-based consumption. Wearables: Rapid growth in consumer-linked medical devices like smart blood pressure monitors and oximeters. Conclusion The medical equipment and supplies market is evolving rapidly with a focus on miniaturization, automation, remote diagnostics, and patient-centric innovations. Coupled with stronger government support, global health digitization, and continuous investments in AI and robotics, the industry is expected to continue its strong growth trajectory through 2030. This report brings together critical data, company actions, and global regulatory dynamics to support decision-making for stakeholders across the healthcare and medtech ecosystem. Request Sample Pages: Comprehensive Medical Devices List DIAGNOSTIC IMAGING EQUIPMENT MRI Machines The global MRI machines market is valued at approximately $7.5 billion in 2024, with expectations to reach around $10.2 billion by 2034. This growth represents a Compound Annual Growth Rate (CAGR) of around 3.5% over the forecast period from 2025 to 2034. Key Competitors: SIGNA Premier, SIGNA Pioneer, SIGNA Explorer, MAGNETOM Vida, MAGNETOM Sola, MAGNETOM Lumina, Ingenia Elition, Ingenia Ambition, MR 5300, Vantage Galan, Vantage Orian, Vantage Elan, Echelon Oval, Echelon Smart Plus, Airis Vento, Embrace Neonatal MRI, Swoop Portable MRI CT Scanners The global CT scanner market was valued at approximately $6.5 billion in 2024, with expectations of reaching around $10 billion by 2034. This projection reflects a robust compound annual growth rate (CAGR) of approximately 4.6% during the forecast period from 2025 to 2034. Key Competitors: Revolution Apex, Revolution Maxima, Revolution EVO, SOMATOM Drive, SOMATOM SOMATOM Spectral CT 7500, Incisive CT, MicroDose SI, Aquilion ONE, Aquilion Lightning, Aquilion Prime, Supria Grande, Supria Prime, CereTom, BodyTom Elite, NeuViz ACE, NeuViz Glory, NeuViz Epoch Ultrasound Systems The global ultrasound systems market is valued at approximately $8.5 billion in 2024 and is projected to reach around $14.5 billion by 2034, demonstrating a robust Compound Annual Growth Rate (CAGR) of about 6.0% during the forecast period from 2025 to 2034. Key Competitors: LOGIQ E10, Voluson E10, Vivid E95, EPIQ Elite, Affiniti, Lumify, ACUSON Sequoia, ACUSON Juniper, ACUSON Redwood, Aplio i-series, Xario, Viamo, Resona, DC-series, TE-series, RS85, HS70, HS60, Arietta, Lisendo, Noblus, MyLab, MyLabOne, MyLabSigma, SII, PX, Edge II, Butterfly iQ, C3 HD3, L7 HD3, PA HD3 X-Ray Equipment The global X-ray equipment market is projected to reach a value of approximately $11.5 billion in 2024, driven by advancements in imaging technologies and a growing prevalence of chronic diseases requiring diagnostic imaging. The market is expected to exhibit robust growth over the forecast period from 2025 to 2034, with a projected market value of about $18 billion by 2034, indicating a Compound Annual Growth Rate (CAGR) of 5.1%. Key Competitors: DRX-Evolution Plus, DRX-Compass, DRX-Mobile Retrofit, Fluoroscan InSight FD, DirectRay DR, Selenia Dimensions, DigitalDiagnost C90, MobileDiagnost wDR, SmartDiagnost, Definium 8000, AMX-4+, Brivo XR515, Ysio Max, Multitom Rax, Mobilett Elara Max, CXDI Control Software NE, RADREX-i, RADspeed Pro, MobileDaRt Evolution MX8, FlexaVision FX-1, FDR D-EVO II, FDR Go, FDR nano, AeroDR, RegaMax, Xpress Mammography Systems The global mammography systems market is valued at approximately $3.5 billion in 2024 and is projected to reach around $5.8 billion by 2034, reflecting a robust compound annual growth rate (CAGR) of 5.2% during the forecast period from 2025 to 2034. Key Competitors: 3Dimensions, Selenia Dimensions, Senographe Pristina, Senographe Crystal Nova, Mammomat Revelation, Mammomat Inspiration Prime, AMULET Innovality, ASPIRE Cristalle, MicroDose SI, MammoGraphe Opertune, Giotto TOMO, Giotto Class, Clarity 3D, Nuance Excel Nuclear Medicine & PET/CT The global nuclear medicine market, particularly in the PET/CT segment, is valued at approximately $6 billion. The market is anticipated to grow significantly, reaching an estimated value of $10 billion by 2034, driven by advancements in imaging technologies and an increasing prevalence of chronic diseases. During the forecast period from 2025 to 2034, the market is projected to experience a Compound Annual Growth Rate (CAGR) of around 5.5%. Key Competitors: Discovery MI, Discovery IQ, Discovery NM/CT 670, Biograph Vision, Biograph mCT, Symbia Intevo, Vereos PET/CT, Ingenuity TF, BrightView, Celesteion, Veriton-CT, Veriton FH, VERITON-CT, D-SPECT, AnyScan, nanoScan, Dedicated Breast PET CARDIOVASCULAR DEVICES Pacemakers & ICDs The global pacemakers and implantable cardioverter-defibrillators (ICDs) market is valued at approximately $10.5 billion in 2024, with a projected value reaching around $15 billion by 2034. This growth trajectory suggests a robust Compound Annual Growth Rate (CAGR) of about 4.5% during the forecast period from 2025 to 2034. Key Competitors: Micra AV, Azure, Cobalt, Visia AF, Assurity MRI, Ellipse, Gallant, Aveir VR, Accolade, Essentio, Dynagen, Emblem, Edora, Etrinsa, Iforia, Inventra, Kora, Reply, Paradym, Virtue DR, Virtue SR Heart Valves The global heart valves market is valued at approximately $12 billion in 2024, with a projected compound annual growth rate (CAGR) of 6.5% from 2025 to 2034, aiming for a market value of around $22 billion by the end of the forecast period. Key Competitors: SAPIEN 3, SAPIEN 3 Ultra, Inspiris Resilia, Evolut PRO+, Evolut FX, Hancock II, Trifecta GT, Portico, NaviGate, Lotus Edge, ACURATE neo2, Perceval, Mitroflow, Crown PRT, On-X, BioGlue, CryoValve SG Coronary Stents The Global Coronary Stents market is anticipated to grow from USD 9.0 Billion in 2023 to USD 12.87 Billion by 2030, at a CAGR of 6.0 % during the forecast period. Key Competitors: Xience Sierra, Xience Skypoint, Absorb GT1, Synergy, Promus PREMIER, Omega, Resolute Onyx, Resolute Integrity, Resolute NX, Ultimaster, Nobori, Gianturco-Roubin II, Orsiro, Pro-Kinetic Energy, Coroflex Please, Coroflex ISAR, VELOcity, Coroflex Please NEO Cardiac Catheters & Guidewires The global market for cardiac catheters and guidewires is valued at approximately $8.5 billion, driven by the increasing prevalence of cardiovascular diseases and technological advancements in minimally invasive procedures. The market is projected to reach around $14 billion by 2034, demonstrating significant growth opportunities. Key Competitors: Radifocus, Glidewire, Fielder, Hi-Torque, Whisper, Pilot, Runthrough, Transend, Spartacore, Roadrunner, Treasure, Laureate, Impress, Flexor, Sion, Miracle Structural Heart Devices The structural heart devices market is poised for significant growth, with a current market value of approximately $10 billion in 2024. This sector is projected to reach around $19 billion by 2034, reflecting robust advancements in technology and increasing demand for minimally invasive procedures. The compound annual growth rate (CAGR) for this period is estimated to be 7.5%. Key Competitors: MitraClip, Amplatzer, TriClip, Pascal, Cardioband, Watchman, Cadera, Intrepid, ASD/PFO Occluders, Figulla, Atrial Flow Regulator, Cardioform, Helex SURGICAL EQUIPMENT The global Surgical Robots market is expected to grow at 17.6% CAGR from 2019 to 2028. It is expected to reach above USD 18.01 billion by 2028 from USD 4.38 billion in 2019. Surgical Robots Key Competitors: da Vinci Xi, da Vinci X, da Vinci SP, Mako SmartRobotics, Mako Total Knee, Mako Total Hip, ROSA Knee, ROSA Hip, ROSA Brain, Hugo RAS, Mazor X Stealth Edition, NAVIO, CORI Surgical System, Monarch Platform, Ottava, Versius, CyberKnife, Radixact, Cirq Robotic Alignment Electrosurgical Units The global electrosurgical units (ESUs) market is poised for significant growth, projected to reach approximately $4.2 billion in value by 2024. The market is expected to expand robustly, with a forecasted value of $7.1 billion by 2034, reflecting a compound annual growth rate (CAGR) of around 5.5% during the period from 2025 to 2034. Key Competitors: ForceTriad, LigaSure, Aquamantys, Harmonic, Enseal, Thunderbeat, ESG-400, UES-40, System 5000, AltaVista, Excalibur Plus, Aaron, Bantam, Specialist PRO, Force FX, Force Argon, Force Triad Laparoscopic Instruments The laparoscopic instruments market is poised for significant growth, with a projected value of approximately $16 billion in 2024. An expected surge in demand for minimally invasive surgical procedures is propelling market expansion. By 2034, the market value is estimated to reach around $28 billion, reflecting a robust Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period from 2025 to 2034. Key Competitors: Hopkins, Tele Pack, Aida, Visera Elite II, Visera 4K UHD, EndoEYE, 1588 4K, X8000, 1488 HD, Endo GIA, Tri-Staple, Echelon Flex, Proximate, AirSeal, FreeHand, MicroFrance, Aesculap Einstein Vision, Aesculap Caiman Surgical Lighting The global surgical lighting market is valued at approximately $1.2 billion in 2024, driven by advancements in medical technology and the increasing demand for minimally invasive surgeries. By 2034, the market is projected to reach around $2.3 billion, reflecting the ongoing shift towards enhanced surgical environments and improved patient outcomes. Key Competitors: iLED, TruLight 5000, LEDion, Harmony, Volista, Pentavision, Visum, L10, L9, Levis, Mira, Simeon, Burton AIM, Burton Apex, Burton Outpatient II, Horizon, Elite, Allegiance Surgical Tables The global surgical tables market is valued at approximately $2.5 billion, driven by advancements in surgical techniques and an increasing volume of surgical procedures. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.8% from 2025 to 2034, with the total market value expected to reach about $4.5 billion by the end of 2034. Key Competitors: 5085 SRT, 4085, Cmax, Epic II, T5, Secure II, Magnus, Alphamaxx, Betamaxx, TruSystem 7500, TruSystem 7000, Modular, Orthopedic, Radiolucent, Quasar, Axia, Operon ORTHOPEDIC DEVICES Hip Replacement Systems The global hip replacement market is poised for significant growth, with an estimated market value of approximately $7.4 billion in 2024. This market is projected to reach about $10.2 billion by 2034, driven by advancing technologies and an increasing elderly population. The compound annual growth rate (CAGR) for this period is anticipated to be around 3.5%, reflecting robust demand amid rising awareness of joint health. Key Competitors: Trident, Accolade TMZF, Meridian, Taperloc, G7, Trabecular Metal, Pinnacle, Corail, Summit, R3, Redapt, Anthology, Novation, Alteon, ExactechGPS, Profemur, Trilogy, Evolution Knee Replacement Systems The knee replacement systems market is poised for significant growth, with a current market value estimated at approximately $21 billion in 2024. The market is projected to reach around $35 billion by 2034, reflecting a substantial increase driven by an aging population and rising incidences of knee-related ailments, including osteoarthritis. This growth translates to a Compound Annual Growth Rate (CAGR) of about 5.2% from 2025 to 2034. Key Competitors: Triathlon, Mako Total Knee, GetAroundKnee, Persona, NexGen, Vanguard, Attune, Sigma, PFC Sigma, Legion, Genesis II, Journey II, Optetrak, Truliant, Advance Spinal Implants The spinal implants market is poised for significant growth, with a current market value estimated at approximately $13.5 billion in 2024. The market is projected to reach around $24 billion by 2034, driven by escalating demand for advanced surgical solutions and an aging global population. The Compound Annual Growth Rate (CAGR) for the forecast period from 2025 to 2034 is anticipated to be about 6.6%. Key Competitors: Infuse, Mastergraft, Expedium, Viper, Mountaineer, SpineJack, PEEK-OPTIMA, Tritanium, XLIF, MAGEC, Pulse, REVOLVE, CALIBER, SECURE-C, M6-C, Firebird, Trinity ELITE Trauma Fixation The global trauma fixation market is valued at approximately $5.2 billion, driven by increasing incidences of traumatic injuries and surgeries worldwide. The market is projected to grow at a significant CAGR of 6.8% during the forecast period of 2025–2034, reaching an estimated value of $10.2 billion by 2034. Key Competitors: T2, AxSOS, Hoffmann 3, NCB, Periarticular, A.L.P.S., LCP, Variable Angle LCP, DePuy Mitek, TRIGEN, Sliding Hip Screw, EVOS, TL-HEX, Limb Reconstruction System, Acu-Loc, DVR, Polarus PATIENT MONITORING SYSTEMS Vital Signs Monitors The global vital signs monitors market is projected to reach approximately $4.2 billion in value by 2024, driven by the increasing prevalence of chronic diseases and the rising demand for home healthcare solutions. Over the forecast period from 2025 to 2034, the market is anticipated to expand significantly, with a projected value of around $7.5 billion by 2034. This growth reflects a Compound Annual Growth Rate (CAGR) of about 6.1%, appealing to investors and stakeholders alike. Key Competitors: IntelliVue MX800, IntelliVue MX450, IntelliVue MX40, Carescape B850, Carescape B650, Carescape B450, Root, Radical-7, Pronto-7, BeneVision N-series, uMEC, VS-series, BSM-6000, BSM-3000, BSM-1700, Xhibit, Qube, 90367, Connex Vital Signs Monitor, Connex ProBP ECG Machines The global ECG machine market is poised to reach approximately $5.2 billion in 2024, driven by the increasing prevalence of cardiovascular diseases and technological advancements in health monitoring. The market is projected to grow at a CAGR of 5.8%, forecasting a value of $8.8 billion by 2034. Key Competitors: Cardiofax, ECG-1550P, ECG-2550, PageWriter TC70, PageWriter TC50, PageWriter TC30, MAC 2000, MAC 1200, MAC 800, Cardiovit AT-102 Plus, AT-101, MS-2010, BeneHeart, D-series, R-series, ELI 380, ELI 280, ELI 230, CP 200, CP 150, CP 100 Pulse Oximeters The pulse oximeter market is projected to reach a value of approximately $3.5 billion in 2024, driven by increasing awareness of health monitoring solutions and a growing patient population with respiratory and cardiovascular conditions. The market is anticipated to experience robust growth, with a projected value of around $6.5 billion by 2034, reflecting a compound annual growth rate (CAGR) of roughly 6.5% during the forecast period from 2025 to 2034. Key Competitors: Rad-97, Rad-8, MightySat, 3230, 2500A, GO2, SureTemp Plus, SatShare, M1191BL, Nellcor, PM1000N, N-600x, BCI, Capnocheck, AVEA, CMS50 series, CONTEC08A, MD300 series, Pulse Ox RESPIRATORY DEVICES Ventilators The global ventilators market is expected to grow at more than 7.6% CAGR from 2022 to 2029. It is expected to reach above USD 2.5 billion by 2029 from USD 1.3 billion in 2020. Key Competitors: Puritan Bennett 980, 840, 560, V680, V60, V30, Carescape R860, Engstrom Carestation, Evita V300, Evita V500, Babylog VN800, HAMILTON-G5, HAMILTON-C6, HAMILTON-T1, Bellavista 1000, CareFusion 3100A, Stellar 150, Lumis 100 VPAP S, Lumis 150 VPAP ST, Servo-i, Servo-n, Servo-Air CPAP/BiPAP Machines The global CPAP/BiPAP machines market is valued at approximately $4.5 billion in 2024, with expectations to reach around $7.8 billion by 2034. This indicates a robust compound annual growth rate (CAGR) of 6.2% during the forecast period from 2025 to 2034. Key Competitors: AirSense 10, AirCurve 10, AirMini, DreamStation, System One, SimplyGo, ICON, SleepStyle, myAirvo 2, IntelliPAP, Blue, DV5 Series, iCH, XT, Wizard, RESmart, G2S, Luna, DreamStar, EcoStar, Nebulizers The global nebulizers market is valued at approximately $2.7 billion in 2024, with projections indicating growth to around $4.5 billion by 2034. This translates to a Compound Annual Growth Rate (CAGR) of about 5.3% during the forecast period from 2025 to 2034. The current market scenario reflects an increasing prevalence of respiratory diseases, such as asthma and COPD, driving the demand for effective drug delivery systems like nebulizers. Key Competitors: CompAir, MicroAir, NE-C801, InnoSpire, SideStream, I-neb, LC Plus, LC Sprint, PARI BOY, Pulmo-Aide, Traveler, VixOne, Aeromist, Whisper Jet, Micro Mist, Beetle, Compact Compressor, PowerNeb, IH21, IH50, IH58 LABORATORY EQUIPMENT Hematology Analyzers The global hematology analyzers market is projected to reach approximately $3.5 billion in 2024, driven by increasing demand for accurate diagnostics and advancements in technology. The market is expected to exhibit a robust compound annual growth rate (CAGR) of around 6.8% from 2025 to 2034, potentially surpassing $6 billion by the end of the forecast period. Key Competitors: XN-Series, XS-Series, pocH-100i, Cell-Dyn Emerald, Cell-Dyn Ruby, Cell-Dyn Sapphire, DxH 900, DxH 690T, Ac·T diff2, BC-6800, BC-5000, BC-2800, Yumizen H500, Yumizen H550, Yumizen H2500, MEK-9100, MEK-8222, MEK-7300 Chemistry Analyzers The global chemistry analyzers market is valued at approximately $11 billion in 2024, with a robust growth trajectory expected over the coming decade. The market is projected to reach around $18 billion by 2034, reflecting a Compound Annual Growth Rate (CAGR) of approximately 5.9% during the forecast period from 2025 to 2034. Key Competitors: cobas 8000, cobas 6000, cobas c 501, Architect ci8200, Architect c8000, Alinity c, Atellica CH 930, Dimension Vista, Advia 1800, AU5800, AU680, DxC 700 AU, Vitros 5600, Vitros 4600, Vitros ECiQ, BS-2000M2, BS-800M2, BS-240 Pro Immunoassay Analyzers The global immunoassay analyzers market is projected to reach a value of approximately $20 billion in 2024, driven by the increasing demand for rapid diagnostic technologies and advancements in healthcare. Over the forecast period from 2025 to 2034, the market is anticipated to grow significantly, reaching an estimated value of $35 billion by 2034, reflecting a robust compound annual growth rate (CAGR) of about 6.5%. Key Competitors: Architect i2000SR, Architect i1000SR, Alinity i, cobas e 801, cobas e 602, cobas e 411, Atellica IM 1300, Centaur XP, Immulite 2000 XPi, DxI 9000, DxI 800, Access 2, Vitros 3600, Vitros ECi, LIAISON XL, LIAISON XS, LIAISON Murex Molecular Diagnostics The molecular diagnostics market is projected to reach a value of approximately $10.5 billion in 2024, driven by increased demand for personalized medicine and advancements in genetic testing technologies. It is expected to grow significantly, with a forecasted market value of $18.2 billion by 2034. This growth reflects a Compound Annual Growth Rate (CAGR) of 5.6% during the 2025–2034 period. Key Competitors: cobas 6800, cobas 4800, LightCycler 480, m2000, Alinity m, ID NOW, GeneXpert, Infinity-48, Infinity-80, Panther, Tigris, Aptima, NucliSENS easyMAG, ARGENE, FilmArray, QIAsymphony, Rotor-Gene Q, QIAstat-Dx DIABETES CARE DEVICES Blood Glucose Monitors The global blood glucose monitors market is valued at approximately $14 billion in 2024 and is projected to reach around $28 billion by 2034. This represents a robust compound annual growth rate (CAGR) of about 7.3% during the forecast period from 2025 to 2034. Key Competitors: FreeStyle Lite, FreeStyle Freedom Lite, FreeStyle Optium Neo, Accu-Chek Guide, Accu-Chek Performa, Accu-Chek Active, OneTouch Ultra 2, OneTouch Verio, OneTouch Select Plus, Contour Next, Contour Plus, Contour XT, Glucocard, Glucocard Shine, Glucocard Expression, Medisafe, Medisafe Fit, Medisafe Mini, Jazz, WaveSense KeyNote, WaveSense Presto Continuous Glucose Monitors The global Continuous Glucose Monitoring (CGM) market is valued at approximately $5.4 billion in 2024, driven by increased prevalence of diabetes and demand for real-time glucose monitoring solutions. The market is projected to grow, reaching an estimated $15.2 billion by 2034, indicating a robust growth trajectory. Key Competitors: G6, G5, G4 Platinum, FreeStyle Libre, FreeStyle Libre 2, FreeStyle Navigator, Guardian Sensor 3, Guardian Connect, Enlite, Eversense, Eversense XL, Eclipse ICGM, GlucoTrack Insulin Pumps The global insulin pump market is valued at approximately $6.5 billion. This market is projected to grow significantly, reaching an estimated $12.1 billion by 2034, driven by the increasing prevalence of diabetes and technological advancements in diabetes management. The projected Compound Annual Growth Rate (CAGR) for the period from 2025 to 2034 is anticipated to be around 6.3%, reflecting robust demand for innovative diabetes care solutions. Key Competitors: MiniMed 780G, MiniMed 670G, MiniMed 630G, t:slim X2, t:lock, t:flex, Omnipod 5, Omnipod DASH, Omnipod Eros, Accu-Chek Insight, Accu-Chek Combo, Accu-Chek Spirit, Vibe, Ping, OneTouch Ping, V-Go, V-Go Prefilled DENTAL EQUIPMENT Dental Chairs The global dental chair market is valued at approximately $1.5 billion, driven by increasing dental health awareness and rising demand for cosmetic dentistry. Projections indicate a robust growth trajectory, with the market expected to reach around $2.9 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 7%. Key Competitors: A-dec 500, A-dec 400, A-dec 300, Sovereign, Compact i, Compact i5, Intego, Teneo, C4+, Estetica E50, Estetica E30, Estetica E70, UltraComfort, UltraTrim, Synthesis, Clesta II, Clesta E, Voyager III, Spirit 3000, Spirit 2000, Chairman Dental Imaging The Global Dental Imaging Market size is expected to grow at more than 9.5% CAGR from 2016 to 2028. It is expected to reach above USD 5.9 billion by 2028 from a little above USD 2 billion in 2016. Key Competitors: CS 8100, CS 9000, CS 9300, Gendex, KaVo, Instrumentarium, ProMax, ProOne, Viso, Orthophos, Galileos, CEREC, PaX-i3D, PaX-Primo, Green-X, Veraviewepocs, Accuitomo, X-era, VGi evo, GiANO HR, 5G Dental Lasers The global dental lasers market is valued at approximately $1.1 billion in 2024 and is projected to reach around $2.3 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of about 7.6% over the forecast period. Key Competitors: Waterlase, Epic X, iLase, LightWalker, TwinLight, SkyPulse, LiteTouch, OpusDent, UltraPulse, Solea, Solea Sleep, SiroLaser, SiroLaser Blue, SiroLaser Advance, Bluephase, Bluephase Style, Bluephase PowerCure OPHTHALMOLOGY EQUIPMENT Ophthalmic Lasers The ophthalmic lasers market is projected to reach approximately $4.5 billion in 2024, reflecting robust demand driven by advancements in laser technologies and increasing prevalence of ocular diseases. For the forecast period from 2025 to 2034, the market is anticipated to grow significantly, reaching an estimated value of $7.2 billion by 2034, representing a Compound Annual Growth Rate (CAGR) of about 5.2%. Key Competitors: Constellation, Centurion, LenSx, Catalys, Stellaris Elite, Whitestar Signature, Victus, Millennium, VisuMax, MEL 90, OPMI Lumera, Triton, Maestro, 3D OCT-1, Quest, OPD-Scan III, RT-5100, EX500, FS200, Refractive Suite Intraocular Lenses The global intraocular lens (IOL) market is poised for substantial growth in 2024, valued at approximately $4.5 billion. Projections indicate a robust expansion, with the market expected to reach around $9.1 billion by 2034, driven by advances in ophthalmic technology and an aging population in need of cataract and refractive surgeries. The projected Compound Annual Growth Rate (CAGR) for the forecast period (2025–2034) stands at 7.2%. Key Competitors: AcrySof, PanOptix, Vivity, Tecnis, Tecnis Symfony, Tecnis Synergy, enVista, LI61AO, Crystalens, AT LISA, AT TORBI, CT LUCIA, Vivinex, AF-1, PC-60AD, RayOne, Superflex, T-flex Diagnostic Equipment The global diagnostic equipment market is valued at approximately $60 billion in 2024, driven by increasing healthcare demands and technological advancements in medical diagnostics. The market is projected to reach around $94 billion by 2034, reflecting a robust growth trajectory. This translates to a Compound Annual Growth Rate (CAGR) of about 4.5% from 2025 to 2034. Key Competitors: Maestro, Triton, TRC-NW8, Cirrus, Clarus, IOLMaster, Spectralis, Anterion, Retina Angiograph, Avanti, iVue, iFusion, Mirante, RS-3000, OPD-Scan, Epic, Phoroptor, Chart Projector WOUND CARE PRODUCTS Advanced Wound Dressings The advanced wound dressings market is poised for significant growth, with an estimated value of approximately $5.3 billion in 2024. This market is projected to reach around $9.6 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of about 6.2% from 2025 to 2034. Key Competitors: Allevyn, Acticoat, Pico, Mepilex, Mepitel, Safetac, Tegaderm, Medipore, Cavilon, DuoDERM, Aquacel, Esteem, Biatain, Triad, Comfeel, Restore, CeraPlus, Adapt Negative Pressure Wound Therapy The global negative pressure wound therapy (NPWT) market is valued at approximately $3.2 billion in 2024, driven by an increasing prevalence of chronic wounds and surgical site infections. With a projected growth trajectory, the market is expected to reach around $5.5 billion by 2034, reflecting a Compound Annual Growth Rate (CAGR) of about 6.0% during the forecast period of 2025 to 2034. Key Competitors: V.A.C., InfoV.A.C., ActiV.A.C., RENASYS, PICO 7, Avance, Avance Solo, Avance CS, PRO-Healion, Cardinal NPWT, LR3, Wound Pro, Versatile 1 INFUSION PUMPS & IV EQUIPMENT Infusion Pumps The global infusion pumps market is valued at approximately $6.5 billion, driven by the rising demand for advanced healthcare technologies and increasing chronic disease prevalence. The market is expected to experience significant growth, with projections suggesting a value of around $10.2 billion by 2034. This indicates a robust Compound Annual Growth Rate (CAGR) of approximately 4.7% during the forecast period from 2025 to 2034. Key Competitors: Sigma Spectrum, Colleague, Flo-Gard, Perfusor Space, Infusomat Space, Outlook, Agilia, Volumat, Perfusor, Plum 360, LifeCare, Symbiq, Medfusion, CADD, Graseby, TE-171, TE-112, TE-331, BeneFusion, VP-series, nPM-series IV Catheters & Accessories The IV catheter market reached a value of approximately $4.5 billion in 2024, with expectations to grow to $8 billion by 2034. This represents a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period from 2025 to 2034. Key Competitors: Insyte, Nexiva, Angiocath, Surflo, Surshield, Surflo-W, Jelco, Protectiv, Delta, Introcan, CONTACT: Irfan Tamboli (Head of Sales) Phone: + 1704 266 3234 Email: sales@
AsiaOne
19-06-2025
- Politics
- AsiaOne
Soldiers, Strykers and 100-degree temps: Inside Trump's border military zone, World News
SANTA TERESA, NM — The weapons system atop a drab green US Army Stryker swivels, its camera shifting downward toward a white Ford F-150 driving slowly along the US-Mexico border. Under the watchful eye of the 26-ton armoured vehicle perched on a sand dune above them, humanitarian volunteers are driving the dirt road next to the border wall to see if they can continue to search for migrant remains inside one of two military zones established along the border by the Trump administration in April and May. Soon, they get their answer. It's not long before an unmarked gray pickup appears, makes a U-turn in the sand, and puts on its siren, here in the desert 5.6 miles (9km) west of the Santa Teresa, New Mexico border crossing. The driver pulls alongside, introduces himself as a US Border Patrol agent, and tells the volunteers they can no longer be there. James Holman, founder of the Battalion Search and Rescue group, whose volunteers also hand water to migrants through the bars of the barrier, acquiesces. Then he vents his frustration. "We're ramping up all this military and taking this public land away, it doesn't make sense, and it's theatre, it's deadly, deadly theatre," says Holman, 59, a former Marine, who is concerned the military zone will push migrants west into even more dangerous desert crossings. They are in one of two so-called "National Defence Areas" set up along 260 miles (418 km) of the US southern border in New Mexico and Texas as part of the Trump administration's military buildup on the border. US President Donald Trump has long shown interest in using the military for civilian law enforcement, sending Marines to Los Angeles this week in their first domestic deployment in over 30 years. The border military zones are one of his most audacious attempts yet to use troops trained for overseas combat in roles normally carried out by Border Patrol or local police. The Army has not made public the zones' boundaries. The New Mexico area may run over three miles into the United States, in places, based on "restricted area" warning signs in English and Spanish posted along State Road 9 parallel to the border. The zones are classified as US Army installations, giving troops the right to temporarily detain and question migrants and other civilian trespassers caught in the areas. Their primary mission is to detect and track illegal border crossers as part of the Trump administration's quest for "100 per cent operational control" of the border at a time when migrant arrests are near an historic low. Along the international boundary, Reuters saw warning signs posted inside the United States around 45 feet north of the border barrier around every 100 metres, facing south. That meant if you had crossed the border and could read them, you were already in the zone. Migrants caught illegally crossing the border into the zones face new trespassing charges on top of unlawful entry to the country, with combined penalties of up to 10 years imprisonment. Attempts to prosecute them for trespassing have floundered. Starting in May, federal judges in Texas and New Mexico have dismissed trespassing charges against migrants caught within the area and acquitted a Peruvian woman brought to trial, ruling there was no evidence they saw signs before entering the zone. Illegal border crossings fell to a record low in March after the Biden administration shut down asylum claims in 2024 and Mexico tightened immigration controls. Trump, who banned people from claiming asylum on the southern border shortly after starting his second term in January, nonetheless says the military areas are needed to repel an "invasion" of human traffickers and drug smugglers. Border buildup In the past four months Trump raised the number of active-duty troops on the border to 8,000 from 2,500 at the end of the Biden administration, according to the US Army. Presidents since Richard Nixon have used regular troops and reservists for support roles on the border. Trump has taken it a step further. The Bureau of Land Management in April transferred 110,000 acres of land in New Mexico, an area seven times the size of Manhattan, to the US Army for three years to establish a first zone. A second was created in May with a transfer of International Boundary and Water Commission land in Texas. The areas are satellites of the Fort Huachuca and Fort Bliss Army bases in Arizona and Texas, respectively. That gives troops the right to hold and question civilian trespassers without the need for Trump to invoke the Insurrection Act. The law lets a president deploy federal forces domestically during events like civil unrest. Some 105 Stryker combat vehicles and around 2,400 troops from the 4th Infantry Division deployed from Colorado Springs in March. They rove in armoured personnel carriers across New Mexico, Texas and Arizona. Reuters saw Strykers concentrated in a roughly 20-mile ribbon from El Paso west to Santa Teresa, one of the 2,000-mile border's busiest and most deadly areas for migrant crossings. The 8-wheeled vehicles, used by Americans in Iraq and Afghanistan, and now by Ukraine in its war with Russia, can be seen parked under a bridge to Mexico, atop a landfill and on a ridge above a gap in the border wall. Their engines run 24/7 to cool crews in the 100 °F (38 °C) plus heat. Vehicles are unarmed but soldiers have personal weapons. Crews take shifts operating the joystick-controlled camera systems that can see for two miles (3.2 km) and have night vision, according to the Army. A person familiar with Strykers, who asked not to be named, said the work was "monotonous" but said it gave soldiers "a sense of purpose." Troops have alerted Border Patrol to 390 illegal crossings in the nearly two months since the first zone was established. They made their first detentions on June 3, holding 3 "illegal aliens" in New Mexico before handing them over to Border Patrol, according to Army spokesperson Geoffrey Carmichael. Border Patrol arrested 39,677 migrants in the El Paso sector in the fiscal year to April, down 78 per cent from the year-earlier period. 'Covered by desert sand' Sitting outside his juice bar in Sunland Park, Harold Gregory says he has seen a sharp drop in migrants entering his store or asking customers for a ride since Strykers arrived. "We feel safer," said Gregory, 38. "They do kind of like intimidate so there's not so many people come this way." In neighbouring Santa Teresa, trade consultant Jerry Pacheco says the optics of combat vehicles are not good as he tries to draw international firms to the town's industrial park. "It's like killing an ant with a sledgehammer," says Pacheco, executive director of the International Business Accelerator, a nonprofit trade counselling programme. "I think having the military down here is more of a political splash." About 90 miles (143 km) west, New Mexico rancher Russell Johnson said he saw five Strykers briefly positioned in a gap in the border barrier on his ranch. [[nid:719122]] He welcomes the zone as an extra layer of security and has testified to the US Congress on illegal border crossers destroying barbed wire fences, cattle thieves driving livestock into Mexico and a pickup stolen at gunpoint by drug smugglers. He is unsure if his home, or over half his ranch, is inside the area but has been assured by US Border Patrol he can continue to work land ranched by his family since 1918. "I don't know, I don't think anyone knows," says Johnson, 37, a former Border Patrol agent, of the zone's boundaries. He says the Army has not communicated rules for hunters with permits to shoot quail and mule deer this fall in the military area, or hikers who start or end the 3,000-mile (4,800km) Continental Divide Trail within it. The Army has been seeking memoranda of understanding with local communities and agencies to continue activities in the New Mexico zone, said Nicole Wieman, a US Army spokesperson. "The MOU process for commercial and recreational activities, such as hunting, mining and ranching, is complex," Wieman said. Jenifer Jones, Republican state representative for Johnson's area, said Americans can keep doing what they did before in the zone. "They can carry their firearms as they would have prior," said Jones, who welcomed the troops to her "neglected" area where only a barbed-wire fence separates the two countries in places. To the east in Las Cruces, the state's second largest city, State Representative Sarah Silva, a Democrat, said the zones have created fear and apprehension "I see this as an occupation of the US Army on our lands," said Silva. Back in desert west of Santa Teresa, Battalion Search and Rescue leader Abbey Carpenter, 67, stands among dunes where the group has discovered the remains of 24 migrants in 18 months, mostly women. She is concerned the area could be absorbed into the military zone. "Who's going to look for these remains if we're not allowed out here," she said, showing the jaw and other uncollected bones of a woman her group reported to local authorities in September. "Will they just be covered up by the desert sands?" [[nid:719147]]
